Order Article Reprints

Baumgarten J, Groener D, Nguyen Ngoc C, Mader N, Chaurasia M, Davis K, Wichert J, Chun FKH, Tselis N, Happel C, et al. Safety and Efficacy of ¹⁷⁷Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing ²²³Radium-Dichloride. Cancers. 2022; 14(3):557. https://doi.org/10.3390/cancers14030557

Baumgarten, Justus, Daniel Groener, Christina Nguyen Ngoc, Nicolai Mader, Maximilian Chaurasia, Karen Davis, Jennifer Wichert, Felix K. H. Chun, Nikolaos Tselis, Christian Happel, and et al. 2022. "Safety and Efficacy of ¹⁷⁷Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing ²²³Radium-Dichloride" Cancers 14, no. 3: 557. https://doi.org/10.3390/cancers14030557

Baumgarten, J., Groener, D., Nguyen Ngoc, C., Mader, N., Chaurasia, M., Davis, K., Wichert, J., Chun, F. K. H., Tselis, N., Happel, C., Grünwald, F., & Sabet, A. (2022). Safety and Efficacy of ¹⁷⁷Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing ²²³Radium-Dichloride. Cancers, 14(3), 557. https://doi.org/10.3390/cancers14030557